AFMD (Affimed Therapeutics) Gross Profitability Margin

Official company branding of Affimed (AFMD)

Affimed is developing innovative cancer immunotherapy while simultaneously implementing eco-friendly water filtration methods in its laboratories. The business's gross margin demonstrates the company's resilience to costs, with the current level standing at 0.00. The pristine condition of the equipment and strict adherence to drug batch release schedules confirm the high efficiency of the organization's production processes.

AFMD Affimed Therapeutics Gross Profitability (07/04/2022 - 05/31/2025)

Financial and market metric breakdowns for Affimed (AFMD)

- current price and projected stock value:
- business market valuation indicators:
Fundamental valuation:Affimed
Signature product of Affimed Therapeutics

This indicator determines production efficiency by measuring the share of profit from product sales minus all direct costs. Analyzing the gross margin after deducting the cost of goods sold allows for the identification of hidden accounting anomalies and an assessment of the business's real scaling potential. The ratio of the difference between revenue and cost of goods sold to total sales volume for Affimed (AFMD) is critical, as the costs of clinical trials for cell activators directly impact final profitability.

Direct competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Profit Margin Agenus Inc. AGEN|Return on Gross Profit CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Gross Profit Rate|Gross Profitability atyrpharma.com ATYR|Gross Margin Adagene Corp ADAG|IMA - Gross Profitability|Gross Profit Rate STTK (Shattuck Labs)|EQ: Gross Margin|Connect Biopharma (CNTB) - Gross Margin|Gross Profitability Immunic|Gross Margin atarabio.com|Gross Margin IFRX|Gross Margin X4 Pharma (XFOR)|Gross Margin ACET (adicetbio.com)|Gross Margin Celularity Inc. CELU|INMB - Gross Profitability|Gross Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Return on Gross Profit|Return on Gross Profit SAB Biotherapeutics Inc.|Return on Gross Profit AKTX|Return on Gross Profit enlivex.com (ENLV)|Gross Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Gross Sales Margin|Gross Margin EDSA (Edesa Biotech Corp)|Return on Sales by Gross Profit iBio (IBIO)|CARM - Gross Profitability|XTL Biopharmaceuticals (XTLB) - Return on Gross Profit|BOLT: Gross Margin|Return on Gross Profit HCW Biologics Inc.|Gross Profitability Aptevo|Gross Return on Sales AIM (AIM ImmunoTech, Inc.)|Gross Margin ADTX|Return on Sales by Gross Profit GRI Bio Corp|Gross Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Gross Profit Margin|Revelation Biosciences Corp - Gross Margin|INDP (Indaptus Therapeutics, Inc.) - Gross Return on Sales|SCNI: Gross Margin|CALI - Return on Sales by Gross Profit|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability